1449 related articles for article (PubMed ID: 23748003)
1. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
2. Hsp70 molecular chaperones and Parkinson's disease.
Witt SN
Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
[TBL] [Abstract][Full Text] [Related]
3. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
[TBL] [Abstract][Full Text] [Related]
4. Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.
Sharma SK; Priya S
Cell Mol Life Sci; 2017 Feb; 74(4):617-629. PubMed ID: 27522545
[TBL] [Abstract][Full Text] [Related]
5. Molecular chaperones and Parkinson's disease.
Hu S; Tan J; Qin L; Lv L; Yan W; Zhang H; Tang B; Wang C
Neurobiol Dis; 2021 Dec; 160():105527. PubMed ID: 34626793
[TBL] [Abstract][Full Text] [Related]
6. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation.
McLean PJ; Kawamata H; Shariff S; Hewett J; Sharma N; Ueda K; Breakefield XO; Hyman BT
J Neurochem; 2002 Nov; 83(4):846-54. PubMed ID: 12421356
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response.
Du Y; Wang F; Zou J; Le W; Dong Q; Wang Z; Shen F; Yu L; Li Y
Neurobiol Aging; 2014 Oct; 35(10):2316-28. PubMed ID: 24866403
[TBL] [Abstract][Full Text] [Related]
8. Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease.
Hinault MP; Farina-Henriquez-Cuendet A; Goloubinoff P
Neurodegener Dis; 2011; 8(6):397-412. PubMed ID: 21411979
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
10. Preventing α-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins.
Cox D; Carver JA; Ecroyd H
Biochim Biophys Acta; 2014 Sep; 1842(9):1830-43. PubMed ID: 24973551
[TBL] [Abstract][Full Text] [Related]
11. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Schulz-Schaeffer WJ
Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
13. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
Sato H; Kato T; Arawaka S
Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
[TBL] [Abstract][Full Text] [Related]
14. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
15. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.
Ebrahimi-Fakhari D; Saidi LJ; Wahlster L
Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
17. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
Kong B; Chae Y; Lee K
Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
[TBL] [Abstract][Full Text] [Related]
19. The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity.
Cox D; Whiten DR; Brown JWP; Horrocks MH; San Gil R; Dobson CM; Klenerman D; van Oijen AM; Ecroyd H
J Biol Chem; 2018 Mar; 293(12):4486-4497. PubMed ID: 29382725
[TBL] [Abstract][Full Text] [Related]
20. [The role of alpha-synuclein in Parkinson's disease].
Miklya I; Pencz N; Hafenscher F; Göltl P
Neuropsychopharmacol Hung; 2014 Jun; 16(2):77-84. PubMed ID: 24978050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
